Water Island Capital’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,372
Closed -$64.1K 93
2025
Q3
$64.1K Buy
+10,372
New +$67.8K 0.01% 83
2023
Q4
Sell
-22,650
Closed -$203K 60
2023
Q3
$203K Buy
22,650
+2,900
+15% +$31.2K 0.02% 73
2023
Q2
$244K Sell
19,750
-3,916
-17% -$41.9K 0.02% 67
2023
Q1
$220K Buy
23,666
+166
+0.7% +$1.72K 0.02% 69
2022
Q4
$247K Buy
23,500
+12,800
+120% +$163K 0.02% 75
2022
Q3
$194K Sell
10,700
-3,841
-26% -$58.1K 0.01% 81
2022
Q2
$206K Buy
+14,541
New +$241K 0.01% 77

Other funds holding AURA

Water Island Capital's AURA Position: Q4 2025 in Review

Water Island Capital sold out of Aura Biosciences (AURA) in Q4 2025, closing a stake of 10,372 shares — an estimated $64.1K sold.

Water Island Capital first reported a position in AURA in Q2 2022 and held it in 7 quarters. The position peaked at $247K in Q4 2022. 117 funds tracked by Wall St. Rank hold AURA as of Q4 2025.

  • Water Island Capital reported no remaining Aura Biosciences position as of Q4 2025 after selling out during the quarter.
  • Water Island Capital sold 10,372 Aura Biosciences shares in Q4 2025, an estimated $64.1K.
  • Water Island Capital first reported a position in Aura Biosciences in Q2 2022 and held it in 7 quarters.
  • Water Island Capital's Aura Biosciences position peaked at $247K in Q4 2022.
  • 117 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2025.

Based on Water Island Capital's 13F filing for Q4 2025, filed 17 Feb 2026.